TYRPHOSTIN AG 1024

TYRPHOSTIN AG 1024 Basic information
Product Name:TYRPHOSTIN AG 1024
Synonyms:AG1024; TYRPHOSTIN AG 1024;AG 1024 - CAS 65678-07-1 - Calbiochem;CS-241;2-[[3-Bromo-5-(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]propanedinitrile;AGS 200;Tyrphostin;2-[[3-Bromo-5-(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]propanedinitrile AGS 200;AG-1024;HY-10253; AG 1024; AGS 200
CAS:65678-07-1
MF:C14H13BrN2O
MW:305.17
EINECS:
Product Categories:
Mol File:65678-07-1.mol
TYRPHOSTIN AG 1024 Structure
TYRPHOSTIN AG 1024 Chemical Properties
storage temp. Sealed in dry,Store in freezer, under -20°C
solubility DMSO: soluble
form solid
color yellow
Safety Information
Safety Statements 22-24/25
WGK Germany 3
MSDS Information
TYRPHOSTIN AG 1024 Usage And Synthesis
DescriptionThe binding of insulin-like growth factor 1 (IGF-1) to the IGF-1 receptor (IGF-1R) initiates a cascade of reactions that promote cell growth and transformation by activating the PI3K/Akt signaling pathway, inhibiting apoptotic pathways, and mediating mitogenic actions. Overexpression of IGF-1R confers tumorigenic potential to cells as well as protection from apoptosis. AG-1024 is a selective inhibitor of IGF-1R that inhibits insulin-stimulated cellular proliferation and IGF-1R autophosphorylation with IC50 values of 0.4 and 7 μM, respectively. At 10 nM, AG-1024 can inhibit proliferation and induce apoptosis in human breast cancer MCF-7 cells, and it inhibits autocrine growth of human prostate cancer DU145 cells with an IC50 value of 2.5 μM.
UsesTyrphostin AG 1024 is an insulin-like growth factor (IGF)-I receptor antagonist.
DefinitionChEBI: 2-[(3-bromo-5-tert-butyl-4-hydroxyphenyl)methylidene]propanedinitrile is an alkylbenzene.
targetIGF-1R
references[1] párrizas m1, gazit a, levitzki a, wertheimer e, leroith d. specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. endocrinology. 1997 apr;138(4):1427-33.
[2] fan p1, agboke fa1, mcdaniel re1, sweeney ee1, zou x1, creswell k1, jordan vc2.inhibition of c-src blocks oestrogen-induced apoptosis and restores oestrogen-stimulated growth in long-term oestrogen-deprived breast cancer cells. eur j cancer. 2014 jan; 50(2):457-68.
TYRPHOSTIN AG 1024 Preparation Products And Raw materials
Olaparib BMS-754807 Rapamycin LY 294002 HYDROCHLORIDE AVP-AEW541 AG 957 Linsitinib TYRPHOSTIN B56 TYRPHOSTIN AG 1296 TYRPHOSTIN AG 879

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.